-
-
-
-
-
-
-
Pre-Open Movers 09/28: (IGC) (CCXI) (SPRO) Higher; (AAOI) (PRGS) (TSLA) Lower (more...)
-
-
-
-
-
-
-
TherapeuticsMD Announces the FDA has Granted AnnoveraTM Marketing Exclusivity as a New Chemical Entity
-
-
-
-
-
-
-
TherapeuticsMD Licenses Population Council’s Novel Segesterone Acetate/ Ethinyl Estradiol One-Year Vaginal Contraceptive System
-
-
-
-
-
-
-
TherapeuticsMD to Present at Goldman Sachs 39th Annual Global Healthcare Conference
-
-
-
-
-
-
-
TherapeuticsMD (TXMD) Has Not Been Informed by FDA About Status of TX-004HR NDA
-
-
-
-
-
-
-
TherapeuticsMD (TXMD) Appoints Jane F. Barlow to Board
-
-
-
-
-
-
-
TherapeuticsMD Announces Fourth Quarter and Full Year 2017 Financial Results
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

